Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity-Reference-Cited by-同舟云学术

Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity

Published:2016-09-19 Issue:12 Volume:1 Page:
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Chan Kuan Rong,Wang Xiaohui,Saron Wilfried A. A.^ORCID,Gan Esther Shuyi,Tan Hwee Cheng,Mok Darren Z. L.,Zhang Summer Li-Xin,Lee Yie Hou,Liang Cui,Wijaya Limin,Ghosh Sujoy^ORCID,Cheung Yin Bun,Tannenbaum Steven R.,Abraham Soman N.,St John Ashley L.,Low Jenny G. H.,Ooi Eng Eong

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

http://www.nature.com/articles/nmicrobiol2016164.pdf

Reference53 articles.

1. Pike, B. L. et al. The origin and prevention of pandemics. Clin. Infect. Dis. 50, 1636–1640 (2010).

2. Fauci, A. S. & Morens, D. M. Zika virus in the Americas—yet another arbovirus threat. N. Engl. J. Med. 374, 601–604 (2016).

3. WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N. Engl. J. Med. 371, 1481–1495 (2014).

4. D'Argenio, D. A. & Wilson, C. B. A decade of vaccines: integrating immunology and vaccinology for rational vaccine design. Immunity 33, 437–440 (2010).

5. Rappuoli, R., Mandl, C. W., Black, S. & De Gregorio, E. Vaccines for the twenty-first century society. Nat. Rev. Immunol. 11, 865–872 (2011).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial;The Lancet Infectious Diseases;2024-08

2. Electron transport chain capacity expands yellow fever vaccine immunogenicity;EMBO Molecular Medicine;2024-05-14

3. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination;Journal of Virology;2024-05-14

4. YF17D‐based vaccines – standing on the shoulders of a giant;European Journal of Immunology;2024-04-03

5. Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection;Nature Communications;2024-02-24